Neurofibromatosis and Schwannoma Cases

Neurofibromatosis encompasses a group of genetic disorders, most notably Types 1 and 2, in which mutations in tumor suppressor genes allow abnormal proliferation of Schwann cells and other nervous system cells, producing benign neurofibromas as well as more dangerous tumors such as malignant peripheral nerve sheath tumors and gliomas. The proteins encoded by the affected genes — including merlin in NF2 and neurofibromin in NF1 — normally regulate cell growth pathways, and understanding how their loss drives tumorigenesis remains central to the work. Researchers are actively investigating why some patients develop cognitive deficits alongside their physical tumors, and how proteins like ezrin interact with merlin to influence tumor behavior at the molecular level. Better answers to these questions could clarify why disease severity varies so widely between individuals and open paths toward targeted therapies beyond surgical removal.

Works

53,030

Total citations

611,795

Keywords

NeurofibromatosisTumor SuppressorSchwann CellsMalignant Peripheral Nerve Sheath TumorsGliomasEzrin Protein